Evidence map›Paper›PMID 32293075›Full record

ArticleGenes, chromosomes & cancer2020

Decreased copy-neutral loss of heterozygosity in African American colorectal cancers.

Gaius J Augustus, Rosa M Xicola, Xavier Llor, Nathan A Ellis

Open access · greenAbstract read
In one paragraph

Article in Genes, chromosomes & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Gaius J AugustusCancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, Arizona, USA.
Rosa M XicolaDepartment of Internal Medicine and Yale Cancer Center, Yale University, Hew Haven, Connecticut, USA.
Xavier LlorDepartment of Internal Medicine and Yale Cancer Center, Yale University, Hew Haven, Connecticut, USA.
Nathan A EllisCancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, Arizona, USA.ORCID 0000-0003-4231-502X
University of Arizona · USYale Cancer Center · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Integrative Cancer Scholars Training GrantT32CA009213 · NCI · UNIVERSITY OF ARIZONA · PI CAREW, JENNIFER S, CURIEL-LEWANDROWSKI, CLARA · 1985 to 2024
$8.6M
Genetic risk factors in African American colorectal cancer patientsU01CA153060 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ELLIS, NATHAN A. · 2010 to 2014
$1.7M
NCATS NIH HHS UL1 TR001863NCI NIH HHS CA009213NCI NIH HHS CA023074NCI NIH HHS CA153060NCI NIH HHS P30 CA023074NCI NIH HHS T32 CA009213NCI NIH HHS U01 CA153060
6 · The paper itself

Abstract

Despite improvements over the past 20 years, African Americans continue to have the highest incidence and mortality rates of colorectal cancer (CRC) in the United States. While previous studies have found that copy number variations (CNVs) occur at similar frequency in African American and White CRCs, copy-neutral loss of heterozygosity (cnLOH) has not been investigated. In the present study, we used publicly available data from The Cancer Genome Atlas (TCGA) as well as data from an African American CRC cohort, the Chicago Colorectal Cancer Consortium (CCCC), to compare frequencies of CNVs and cnLOH events in CRCs in the two racial groups. Using genotype microarray data, we analyzed large-scale CNV and cnLOH events from 166 microsatellite stable CRCs-31 and 39 African American CRCs from TCGA and the CCCC, respectively, and 96 White CRCs from TCGA. As reported previously, the frequencies of CNVs were similar between African American and White CRCs; however, there was a significantly lower frequency of cnLOH events in African American CRCs compared to White CRCs, even after adjusting for demographic and clinical covariates. Although larger differences for chromosome 18 were observed, a lower frequency of cnLOH events in African American CRCs was observed for nearly all chromosomes. These results suggest that mechanistic differences, including differences in the frequency of cnLOH, could contribute to clinicopathological disparities between African Americans and Whites. Additionally, we observed a previously uncharacterized phenomenon we refer to as small interstitial cnLOH, in which segments of chromosomes from 1 to 5 Mb long were affected by cnLOH.

Indexed as

Loss of HeterozygosityAgedBlack or African AmericanChromosomes, Human, Pair 18Colorectal NeoplasmsDNA Copy Number VariationsFemaleHumansMaleMiddle AgedAfrican American colorectal cancercopy-neutral loss of heterozygositycopy number variationgenotype and microarray dataThe Cancer Genome Atlas

Identifiers

PMID32293075
PMCPMC8045478
OpenAlexW3015879535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.